NCT05943665: MDMA for AUD/PTSD Comorbidity
- State
- Completed
- Phase
- Phase 2
- People
- 22 taking part
- Started
- 6 Feb 2024
- Primary completion
- 21 Jan 2026
- Arms
- MDMA-AT
- Results
- None posted
- 13 Jul 2023: Trial registered
- 6 Feb 2024: Trial started
- 30 Jan 2026: Trial completed